The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
A Shape-Based 3-D Scaffold Hopping Method and Its Application to a Bacterial Protein−Protein Interaction
Open accessAbstract
In this paper, we describe the first prospective application of the shape-comparison program ROCS (Rapid Overlay of Chemical Structures) to find new scaffolds for small molecule inhibitors of the ZipA-FtsZ protein-protein interaction, a proposed antibacterial target. The shape comparisons are made relative to the crystallographically determined, bioactive conformation of a high-throughput screening (HTS) hit. The use of ROCS led to the identification of a set of novel, weakly binding inhibitors with scaffolds presenting synthetic opportunities to further optimize biological affinity and lacking development issues associated with the HTS lead. These ROCS-identified scaffolds would have been missed using other structural similarity approaches such as ISIS 2D fingerprints. X-ray crystallographic analysis of one of the new inhibitors bound to ZipA reveals that the shape comparison approach very accurately predicted the binding mode. These experimental results validate this use of ROCS for chemotype switching or "lead hopping" and suggest that it is of general interest for lead identification in drug discovery endeavors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AMoRe: an automated package for molecular replacement
Navaza, J. (1994) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767393007597 · Cited by 4,953
Reoptimization of MDL Keys for Use in Drug Discovery
Durant, J. L., Leland, B. A., Henry, D. R., & Nourse, J. G. (2002) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci010132r · Cited by 1,862
Ligand efficiency: a useful metric for lead selection
Hopkins, A. L., Groom, C. R., & Alex, A. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03069-7 · Cited by 1,846
Wang, J., Morin, P., Wang, W., & Kollman, P. A. (2001) · Journal of the American Chemical Society · doi:10.1021/ja003834q · Cited by 708
Hale, C. A., & de Boer, P. A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81838-3 · Cited by 506
GRANT, J. A., GALLARDO, M. A., & PICKUP, B. T. (1996) · Journal of Computational Chemistry · doi:10.1002/(sici)1096-987x(19961115)17:14<1653::aid-jcc7>3.0.co;2-k · Cited by 502
Self-citationBACTERIAL CELL DIVISION AND THE Z RING
Lutkenhaus, J., & Addinall, S. G. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.93 · Cited by 465
Inhibition of Protein−Protein Association by Small Molecules: Approaches and Progress
Toogood, P. L. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010468s · Cited by 281
Mosyak, L. (2000) · The EMBO Journal · doi:10.1093/emboj/19.13.3179 · Cited by 276
Self-citationA Gaussian Description of Molecular Shape
Grant, J. A., & Pickup, B. T. (1995) · The Journal of Physical Chemistry · doi:10.1021/j100011a016 · Cited by 273
Self-citationA Gaussian Description of Molecular Shape
Grant, J. A., & Pickup, B. T. (1996) · The Journal of Physical Chemistry · doi:10.1021/jp953707u · Cited by 229
Self-citationAntagonists of protein–protein interactions
Cochran, A. G. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00106-x · Cited by 228
Spencer, R. W. (1998) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(199824)61:1<61::aid-bit11>3.0.co;2-c · Cited by 123
Kenny, C. H., Ding, W., Kelleher, K. S., Benard, S., Dushin, E. G., Sutherland, A. G., Mosyak, L., Kriz, R., & Ellestad, G. A. (2003) · Analytical Biochemistry · doi:10.1016/j.ab.2003.08.033 · Cited by 76
Self-citationA diverse set of oligomeric class II MHC-peptide complexes for probing T-cell receptor interactions
Cochran, J. R., & Stern, L. J. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00019-3 · Cited by 64
Design and synthesis of indolo[2,3-a]quinolizin-7-one inhibitors of the ZipA–FtsZ interaction
Jennings, L. D., Foreman, K. W., Rush, T. S., Tsao, D. H. H., Mosyak, L., Li, Y., Sukhdeo, M. N., Ding, W., Dushin, E. G., Kenny, C. H., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.01.028 · Cited by 60
Self-citationStructure-based design of carboxybiphenylindole inhibitors of the ZipA–FtsZ interaction
Sutherland, A. G., Alvarez, J., Ding, W., Foreman, K. W., Kenny, C. H., Labthavikul, P., Mosyak, L., Petersen, P. J., Rush, T. S., Ruzin, A. V., et al. (2003) · Organic & Biomolecular Chemistry · doi:10.1039/b312016c · Cited by 54
Self-citationPromiscuity: what protects us, perplexes us
Redinbo, M. R. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03087-9 · Cited by 39
Solvation-Based Scoring for High Throughput Docking
Rush, T. S., Manas, E. S., Tawa, G. J., et al. (2005) · Drug discovery series · doi:10.1201/9781420028775.ch10 · Cited by 9
Self-citation
Cited by
Computational Methods in Drug Discovery
Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007336 · Cited by 2,160
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
Wells, J. A., & McClendon, C. L. (2007) · Nature · doi:10.1038/nature06526 · Cited by 1,960
Enumeration of 166 Billion Organic Small Molecules in the Chemical Universe Database GDB-17
Ruddigkeit, L., van Deursen, R., Blum, L. C., & Reymond, J.-L. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300415d · Cited by 1,505
Machine learning in chemoinformatics and drug discovery
Lo, Y.-C., Rensi, S. E., Torng, W., & Altman, R. B. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.05.010 · Cited by 960
A Survey of the Role of Noncovalent Sulfur Interactions in Drug Design
Beno, B. R., Yeung, K.-S., Bartberger, M. D., Pennington, L. D., & Meanwell, N. A. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501853m · Cited by 772
Metadata
- Authors
- Rush, T. S., Grant, J. A., Mosyak, L., & Nicholls, A.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2005-02-10
- Volume
- 48
- Issue
- 5
- Pages
- 1489-1495
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2075186867
- Cited by
- 600
- References
- 19
- FWCI
- 19.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.